Physician profile
Danielle Choate
NPI 1962891689
$1,057.07
in general payments reported to CMS, 2019-2025
20 companies · $84.61 in 2025
The $84.61 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.91 · 2022: $343 · 2023: $376 · 2024: $234 · 2025: $84.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $237.52 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $184.75 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $85.74 | 2022-2025 | Breztri, Farxiga |
| Glaxosmithkline, LLC. | $79.34 | 2022-2023 | Trelegy Ellipta |
| Novo Nordisk INC | $75.34 | 2022-2023 | Wegovy, Rybelsus, Ozempic |
| Biohaven Pharmaceutical Holding Company LTD. | $60.88 | 2022 | |
| Abbott Laboratories | $50.55 | 2021-2023 | Freestyle Libre 3 |
| Baxter Healthcare | $41.23 | 2022 | |
| Merck Sharp & Dohme LLC | $33.79 | 2022-2023 | Verquvo, Steglatro |
| Pfizer INC. | $26.20 | 2023 | |
| Novartis Pharmaceuticals Corporation | $25.24 | 2022-2023 | |
| Collegium Pharmaceutical, INC. | $23.03 | 2025 | Jornay Pm |
| Phathom Pharmaceuticals, INC. | $19.42 | 2024 | Voquezna |
| Ironshore Pharmaceuticals INC. | $19.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.41 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $17.15 | 2024 | |
| Axsome Therapeutics, INC. | $16.42 | 2025 | Auvelity |
| Otsuka America Pharmaceutical, INC. | $15.43 | 2023 | Rexulti |
| Amgen INC. | $14.30 | 2024 | Prolia, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.93 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Choate listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.